APPLICATIONS PUBLISHED 9 JUNE 2004
Published: 1-Dec-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Preparation of sustained release pharmaceutical compsn
SmartDrug Systems 1424994*
A bio-security system
Bimeda Research and Development 1424995*
Method for the production of inhalation powders
Boehringer Ingelheim Pharma 1424996*
Amino acid modulated extended release dosage form
Scolr 1424997*
Synthesis and use of reagents for improved DNA lipoprotection and/or slow release prodrug and drug therapies
The Trustees of the University of Pennsylvania 1424998*
Use of C2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity
Aventis Pharma Deutschland 1424999*
Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
Aventis Pharma Deutschland 1425000*
Phenethanolamine derivatives for treatment of respiratory diseases
Glaxo Group 1425001*
Aryloypropylamines as chemosensitising agents in the treatment of cancer
Ramot at Tel Aviv University 1425002*
Substituted N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
AstraZeneca 1425003*
Use of compounds as functional antagonists to the central cannabinoid receptors
Research & Innovation Soc 1425004*
Pharmaceutical compsn comprising lumiracoxib
Novartis 1425005*
Reference control for high-sensitivity C-reactive protein testing
Bio-Rad Laboratories 1425006*
Use of C2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
Aventis Pharma Deutschland 1425007*
Use of substituted aminomethyl chromans in the treatment of movement disorders
Merck Patent 1425008*
Peptide arginals and methods for treating disseminated intravascular coagulation
Ivax Institute for Drug Research 1425009*
Substituted indoles and their use as integrin antagonists
3-Dimensional Pharmaceuticals 1425010*
Enhancement of learning and memory and treatment of amnesia
Carlsbad Technology 1425011*
Antihelminthic drugs as a treatment for hyperproliferative diseases
Board of Regents, The University of Texas System; Introgen Therapeutics 1425012*
Compsns that bind antiterminator RNA and assay for screening for such compsns
Hines, Jennifer; Bergmeier 1425013*
Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as PPAR activators
Aventis Pharma Deutschland 1425014*
Tetrahydroquinoline derivatives as antithrombitic agents
Bristol-Myers Squibb 1425015*
Compsns and methods for treating cancer
Minerva Biotechnologies Corp 1425016*
Combination of an adenosine A2A receptor antagonist and an antidepressant or anxiolytic
Schering Corp 1425017*
Combined preparation containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
Aventis Pharma 1425018*
Pharmaceutical compsn
Bentley Pharmaceuticals 1425019*
Methods and compsns for treating apoptosis related disorders
Tatton Technologies 1425020*
Physiological method of improving vision
Nolan, Gerard 1425021*
Mutagenic nucleoside analogues for the treatment of viral disease
Koronis Pharmaceuticals 1425022*
G protein-coupled receptor assay
Wyeth 1425023*
Porous extracellular matrix scaffold and method
Depuy Products 1425024*
Ayurvedic compsn for diabetes
Hettigoda, Victor 1425025*
Pharmaceutical compsn containing Valeriana officinalis extract
Max Zeller Soehne 1425026*
Method and compsn for treatment of wounds and burns
Hnat. Thomas M 1425027*
Use of IL-18 inhibitors for the treatment or prevention of sepsis
Yeda Research & Development 1425028*
Peptidomimetics of biologically active metalloproteins
Palatin Technologies 1425029*
Non-oxidatively metabolised compounds and compsns, synthetic pathways therefor, and uses thereof
Aryx Therapeutics 1425030*
HDL for the treatment of of stroke and other ischaemic conditions
ZLB Bioplasma 1425031*
Use of HCG in controlled ovarian hyperstimulation
Applied Research Systems 1425032*
Use of HCG and LH in controlled ovarian hyperstimulation
Applied Research Systems 1425033*
Method for treating coumarin-induced haemorrhage
ZymoGenetics 1425034*
Use of biologically-active HIV-1 TAT, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventative or therapeutic vaccination and/or to treat other diseases
Istituto Superiore di Sanite 1425035*
Virus coat protein/receptor chimeras and methods of use
University of Maryland Biotechnology Institute 1425036*
Bacterial vaccine
Acambis Research 1425037*
Attenuated bacteria useful in vaccines
Acambis Research 1425038*
